Corrine Savill - Chief Business Officer at Cullinan Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer
Stock Symbol
CGEM on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Corrine Savill since 4/23/2024

Holdings reported by Corrine Savill for Cullinan Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 241K $3.01M $12.51 Feb 19, 2025 Direct
Stock Option (Right to Buy) 75K Feb 19, 2025 Direct Common Stock

Transactions reported by Corrine Savill for Cullinan Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.